These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19802976)

  • 21. Ceftazidime-Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients: Results From the INFORM Surveillance Program (United States, 2011-2015).
    Sader HS; Huband MD; Duncan LR; Flamm RK
    Pediatr Infect Dis J; 2018 Jun; 37(6):549-554. PubMed ID: 29206750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
    Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
    World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa.
    Lamp KC; Rybak MJ; McGrath BJ; Summers KK
    Antimicrob Agents Chemother; 1996 Jan; 40(1):247-52. PubMed ID: 8787917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
    Drenjancević D; Vranes J; Bedenić B; Sakić-Zdravcević K
    Coll Antropol; 2007 Mar; 31(1):221-5. PubMed ID: 17598405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa.
    Bauernfeind A
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():111-7. PubMed ID: 19810172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
    Sutherland CA; Verastegui JE; Nicolau DP
    Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):39. PubMed ID: 27316973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections.
    Stone GG; Bradford PA; Yates K; Newell P
    J Antimicrob Chemother; 2017 May; 72(5):1396-1399. PubMed ID: 28088768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.
    Mouton JW; den Hollander JG
    Antimicrob Agents Chemother; 1994 May; 38(5):931-6. PubMed ID: 8067772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in-vitro activity of ceftazidime compared with that of other cephalosporins.
    Bint AJ; Yeoman P; Kilburn P; Anderson R; Stansfield E
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():47-51. PubMed ID: 19802968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftazidime: comparative in-vitro study.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An experimental study on the release of endotoxin from gram negative bacteria induced by antibiotics].
    Xu N; Yuan J; Xiao G; Zheng J; Qin X
    Zhonghua Shao Shang Za Zhi; 2001 Apr; 17(2):75-9. PubMed ID: 11876914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae.
    Thabaut A; Durosoir JL; Saliou P
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():123-5. PubMed ID: 19810174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial properties of SCE-2787, a new cephem antibiotic.
    Nakao M; Noji Y; Iwahi T; Yamazaki T
    J Antimicrob Chemother; 1992 May; 29(5):509-18. PubMed ID: 1624391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial activity of sucralfate against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa in batch and continuous culture.
    West AP; Abdul S; Sherratt MJ; Inglis TJ
    Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):869-71. PubMed ID: 8112362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E; Zer Y; Eksi F
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftazidime, a broad spectrum cephalosporin with activity against Ps. aeruginosa.
    O'Callaghan H
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(4):449-53. PubMed ID: 3100612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biofilm susceptibility to metal toxicity.
    Harrison JJ; Ceri H; Stremick CA; Turner RJ
    Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative evaluation of the antibacterial activity of aminoglycosides by means of microcalorimetry].
    Chernykh VM; Nazarov AD; Samoĭlova LN; Treskina OS; Kalabukhova NF
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):32-5. PubMed ID: 3105431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.